IBS Clinical Trial - A Study of Probiotics in IBS Subjects

Status Completed

Clinical Trial Summary

For the current study, the primary outcome is to evaluate the effect of IP on abdominal pain.

The secondary outcome is to assess the effect of IP on IBS-Symptom Severity, IBS-related quality of life, stool form and consistency and on mental status.

Thus providing an effective objective in improving the gut health and symptomatic relief in IBS patients.

Clinical Trial Description

This study aims to determine the effect of probiotics, as the investigational products (IPs) in subjects satisfying the Rome IV criteria for IBS. Three hundred and sixty six subjects between 18 to 70 years of age and with a positive diagnosis of Rome IV IBS criteria (IBS-C, D, M and U types) and moderate to severe abdominal pain intensity will be recruited in a multi-center, double-blind, parallel group, placebo-controlled randomized trial. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03482765
Study type	Interventional
Source	Vedic Lifesciences Pvt. Ltd.
Contact
Status	Completed
Phase	N/A
Start date	March 30, 2018
Completion date	June 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04677881` - Health Effects of Different Types of Bread	N/A
Completed	`NCT02293343` - 24 Hrs Histamine Profile in Healthy Persons and Patients With Food Intolerance	N/A
Completed	`NCT01717404` - Effects of Mexiletine on Colonic Transit in a Patient With Irritable Bowel Syndrome - Constipation (IBS-C)	Phase 1
Withdrawn	`NCT02313207` - Confocal Laser Endomicroscopy in IBS Patients	N/A
Completed	`NCT02937506` - Patient Satisfaction With Propofol for Out Patient Colonoscopy	Phase 4
Terminated	`NCT05579444` - Systems Biology of Gastrointestinal and Related Diseases
Completed	`NCT02419963` - Analyzing IBS to Identify Biomarkers and Microbiome Signatures	N/A
Recruiting	`NCT06389851` - Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLD	N/A
Recruiting	`NCT05815602` - Ebastine Versus Mebeverine in IBS Patients	Phase 3
Completed	`NCT03986476` - The Effect of Two Probiotic Products on the Intestinal Barrier Function in Patients With Irritable Bowel Syndrome	N/A
Recruiting	`NCT06275906` - Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.	N/A
Not yet recruiting	`NCT05737277` - Gabapral in Pediatric IBS	N/A
Active, not recruiting	`NCT05718505` - Comparison of the Atmo Motility Gas Capsule System to the Reference Standard	N/A
Recruiting	`NCT06072287` - The Living With a Long-Term Condition Study
Completed	`NCT04953728` - Optimization of Transcutaneous Electrical Acustimulation (TEA) Modalities for Treatment of IBS-C	N/A
Completed	`NCT02681666` - Mindfulness-Based Eating in Patients With Irritable Bowel Syndrome	N/A
Completed	`NCT02981888` - Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome
Completed	`NCT01667627` - Probiotic in Irritable Bowel Syndrome (IBS) Patients With Diarrhea	Phase 4
Recruiting	`NCT01779765` - The Efficacy of Hydrolyzed Guar Gum ( PHGG) in the Treatment of Patients With Irritable Bowel Syndrome (IBS)	Phase 4
Completed	`NCT02009618` - The Effects of Rifaximin Therapy in Irritable Bowel Syndrome	N/A